{'fraction_non_alphanumeric': 0.025423728813559324, 'fraction_numerical': 0.005649717514124294, 'mean_word_length': 5.05982905982906, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
For science in Latin America, 'a fascinating challenge'.

Across Latin America, researchers have felt conflicting pressures from the COVID-19 pandemic. They have raced to contribute their expertise to the worst public health crisis in a century and demonstrate that several decades of investment in research—including the capacity to run large clinical trials—has paid off. At the same time, the pandemic has created deep economic and financial problems for the region, which faces a projected 5.3% contraction in gross domestic product this year. The resulting cuts are hitting science hard and threatening hard-won gains; some worry the fallout from the pandemic may lead to an exodus of young researchers.